{"component": "definition", "props": {"groups": [{"snippet_links": [{"key": "the-production", "type": "clause", "offset": [6, 20]}, {"key": "product-sku", "type": "definition", "offset": [51, 62]}, {"key": "step-change", "type": "definition", "offset": [99, 110]}, {"key": "minimum-order-quantity", "type": "clause", "offset": [132, 154]}, {"key": "each-case", "type": "definition", "offset": [159, 168]}, {"key": "as-specified", "type": "clause", "offset": [170, 182]}, {"key": "facility-addendum", "type": "definition", "offset": [201, 218]}], "size": 4, "samples": [{"hash": "6xHbbzWII8u", "uri": "/contracts/6xHbbzWII8u#batch-size", "label": "Manufacturing and Supply Agreement (Viatris Inc)", "score": 31.8829574585, "published": true}, {"hash": "21uesT8iKXH", "uri": "/contracts/21uesT8iKXH#batch-size", "label": "Manufacturing and Supply Agreement (Viatris Inc)", "score": 31.8829574585, "published": true}, {"hash": "eJCm2dAc7HZ", "uri": "/contracts/eJCm2dAc7HZ#batch-size", "label": "Manufacturing and Supply Agreement (Upjohn Inc)", "score": 31.4449005127, "published": true}], "snippet": "means the production quantity for a given run of a Product SKU and \u201cIncrements\u201d means the quantity step change above the applicable Minimum Order Quantity, in each case, as specified in the applicable Facility Addendum.", "hash": "52de66e717f66ee8d5fc33a27c7a6950", "id": 1}, {"snippet_links": [{"key": "quantity-of", "type": "clause", "offset": [10, 21]}, {"key": "production-run", "type": "definition", "offset": [52, 66]}, {"key": "in-accordance-with", "type": "clause", "offset": [82, 100]}], "size": 4, "samples": [{"hash": "bbJzsJem1mp", "uri": "/contracts/bbJzsJem1mp#batch-size", "label": "Commercial Supply and License Agreement", "score": 31.3408622742, "published": true}, {"hash": "j8lVXiM7Jtq", "uri": "/contracts/j8lVXiM7Jtq#batch-size", "label": "Financing Agreement (NeurogesX Inc)", "score": 21.6078033447, "published": true}, {"hash": "kgu3kAtGkZ4", "uri": "/contracts/kgu3kAtGkZ4#batch-size", "label": "Commercial Supply and License Agreement (NeurogesX Inc)", "score": 21.0, "published": true}], "snippet": "means the quantity of Patches produced from a [***] production run as established in accordance with Section 2.4(a).", "hash": "c57a44285bcdccd29f2e4f9fbdf77470", "id": 2}, {"snippet_links": [], "size": 4, "samples": [{"hash": "6xHbbzWII8u", "uri": "/contracts/6xHbbzWII8u#batch-size", "label": "Manufacturing and Supply Agreement (Viatris Inc)", "score": 31.8829574585, "published": true}, {"hash": "21uesT8iKXH", "uri": "/contracts/21uesT8iKXH#batch-size", "label": "Manufacturing and Supply Agreement (Viatris Inc)", "score": 31.8829574585, "published": true}, {"hash": "eJCm2dAc7HZ", "uri": "/contracts/eJCm2dAc7HZ#batch-size", "label": "Manufacturing and Supply Agreement (Upjohn Inc)", "score": 31.4449005127, "published": true}], "snippet": "shall have the meaning set forth in Section 2.4(e)(ii).", "hash": "2856f795b4fc71d5db71dc0948fb078b", "id": 3}, {"snippet_links": [{"key": "from-time-to-time", "type": "clause", "offset": [109, 126]}, {"key": "agree-to", "type": "clause", "offset": [143, 151]}, {"key": "the-parties-shall", "type": "clause", "offset": [180, 197]}, {"key": "change-of", "type": "definition", "offset": [243, 252]}, {"key": "the-purchase-price", "type": "clause", "offset": [253, 271]}], "size": 2, "samples": [{"hash": "N3gyooldlQ", "uri": "/contracts/N3gyooldlQ#batch-size", "label": "Manufacturing and Supply Agreement (Biofrontera AG)", "score": 29.0985622406, "published": true}, {"hash": "23XOupfTuMO", "uri": "/contracts/23XOupfTuMO#batch-size", "label": "Manufacturing and Supply Agreement (Biofrontera AG)", "score": 28.9726219177, "published": true}], "snippet": "means appr. [***] (in words: [***], range from [***]) of Product or such other size as the Parties may agree from time to time. If the Parties agree to change the Batch Size, then the Parties shall at the same time agree about a corresponding change of the Purchase Price.", "hash": "c51b0b81ae1148a160a74cd721ba9dc5", "id": 4}, {"snippet_links": [{"key": "the-product", "type": "definition", "offset": [34, 45]}, {"key": "number-of-units", "type": "clause", "offset": [59, 74]}, {"key": "schedule-a", "type": "definition", "offset": [108, 118]}], "size": 2, "samples": [{"hash": "2yxYK4FCbWR", "uri": "/contracts/2yxYK4FCbWR#batch-size", "label": "Contract Manufacturing Agreement (Medicines Co /De)", "score": 23.3545513153, "published": true}], "snippet": "means the estimated batch size of the Product (measured in number of units of such Product) as set forth in Schedule A;", "hash": "ed5c0fc204b84b6387b932a0ae96316c", "id": 5}, {"snippet_links": [], "size": 1, "samples": [{"hash": "lJlHjVPSTa0", "uri": "https://www.sec.gov/Archives/edgar/data/1532079/000127956915001663/v416297_ex10-3.htm", "label": "Cynapsus Therapeutics Inc.", "score": 12.6153316498, "published": false}], "snippet": "Mix: Apo Layer:", "hash": "73eb1354ec6b3bd9822ac8c555f6cbde", "id": 6}, {"snippet_links": [{"key": "number-of-units", "type": "clause", "offset": [10, 25]}, {"key": "finished-product", "type": "definition", "offset": [38, 54]}, {"key": "with-respect-to", "type": "clause", "offset": [134, 149]}, {"key": "date-of-this-agreement", "type": "clause", "offset": [189, 211]}, {"key": "on-schedule", "type": "definition", "offset": [225, 236]}], "size": 1, "samples": [{"hash": "9AiX35DLIip", "uri": "/contracts/9AiX35DLIip#batch-size", "label": "Product Purchase Agreement (Adams Respiratory Therapeutics, Inc.)", "score": 18.0, "published": true}], "snippet": "means the number of units of a SKU of Finished Product expected to be yielded from a full Batch of such SKU. The estimated Batch Size with respect to each SKU of Finished Product as of the date of this Agreement is described on Schedule 1.4 hereto.", "hash": "48d83bca7cfc25682a7d49419c9e5a26", "id": 7}, {"snippet_links": [{"key": "sales-year", "type": "clause", "offset": [20, 30]}, {"key": "allocated-to", "type": "definition", "offset": [170, 182]}, {"key": "commercial-sales", "type": "clause", "offset": [193, 209]}, {"key": "commercially-reasonable-efforts", "type": "definition", "offset": [254, 285]}, {"key": "reasonable-request", "type": "definition", "offset": [337, 355]}], "size": 1, "samples": [{"hash": "grBU9eN0JFA", "uri": "/contracts/grBU9eN0JFA#batch-size", "label": "License and Supply Agreement (Cumberland Pharmaceuticals Inc)", "score": 27.1984939575, "published": true}], "snippet": "means, for each Net Sales Year, [***] Units for commercial sale or [***] Units for sample distribution or any combination thereof where the amount of individual blisters allocated to Units for commercial sales is in increments of [***]. GEL will use its commercially reasonable efforts to reduce or increase the Batch Size to meet CPI\u2019s reasonable request.", "hash": "22b4b547c2eaf7c808c8d6cb524a2b30", "id": 8}, {"snippet_links": [{"key": "raw-material", "type": "definition", "offset": [20, 32]}], "size": 1, "samples": [{"hash": "h21zj75VvGk", "uri": "/contracts/h21zj75VvGk#batch-size", "label": "Supply Agreement (Dusa Pharmaceuticals Inc)", "score": 13.0, "published": true}], "snippet": "[c.i.] TABLETS Item RAW MATERIAL NAME AMOUNT / QUANTITY ID # UNIT (mg) REQUIRED (Kg) PART - C", "hash": "0e010ea7df4f4318f3c474ab08dcd24e", "id": 9}, {"snippet_links": [{"key": "quantity-of", "type": "clause", "offset": [10, 21]}, {"key": "date-of-this-agreement", "type": "clause", "offset": [196, 218]}], "size": 1, "samples": [{"hash": "9AiX35DLIip", "uri": "/contracts/9AiX35DLIip#batch-size", "label": "Product Purchase Agreement (Adams Respiratory Therapeutics, Inc.)", "score": 18.0, "published": true}], "snippet": "means the quantity of Coated Resin or Uncoated Resin expected to be yielded from a full Batch of Coated Resin or Uncoated Resin, as applicable. The estimated Batch Size for Coated Resin as of the date of this Agreement is * of Coated Resin per Batch. The estimated Batch Size for Uncoated Resin as of the date of this Agreement is * of Uncoated Resin per Batch.", "hash": "ab48dc50bf88d5ab9ffb72e6ae5b77ba", "id": 10}], "next_curs": "ClcSUWoVc35sYXdpbnNpZGVyY29udHJhY3RzcjMLEhpEZWZpbml0aW9uU25pcHBldEdyb3VwX3Y1NiITYmF0Y2gtc2l6ZSMwMDAwMDAwYQyiAQJlbhgAIAA=", "definition": {"title": "Batch Size", "size": 21, "snippet": "means the production quantity for a given run of a Product SKU and \u201cIncrements\u201d means the quantity step change above the applicable Minimum Order Quantity, in each case, as specified in the applicable Facility Addendum.", "id": "batch-size", "examples": ["Unless otherwise agreed, the quantities specified in each order shall be a [***] of the <strong>Batch Size</strong>.", "The Parties agree to use good faith efforts to establish the <strong>Batch Size</strong> by mutual written agreement after manufacture of the first [***] batches of Product based on actual <strong>batch sizes</strong> for production hereunder; provided unfit such time the <strong>Batch Size</strong> for purposes of this Agreement shall be deemed to be the Theoretical <strong>Batch Size</strong> set forth in Exhibit A.", "Zogenix shall place Firm Orders for the Products in whole multiples of the Standard <strong>Batch Size</strong>.", "Each Purchase Order shall be a multiple of the Minimum <strong>Batch Size</strong> of the applicable Product as set out in the Specifications.", "Purchase Orders shall be made in writing at least [***] calendar days prior to the Delivery Date for the first order and [***] calendar days prior to the Delivery Date for any subsequent order, and shall determine quantity of Product ordered, stated as multiples of the <strong>Batch Size</strong>, and the Delivery Date for the ordered Product.", "Any change that is in connection with the Minimum <strong>Batch Size</strong> and in connection with a mandatory change resulting from a Regulatory Authority communication, shall not be considered a Change Request sponsored by Ovamed.", "After the First Submission, the Parties shall discuss in good faith and agree upon an annual minimum number of Units of Commercial Product to be ordered by CPP, which number shall be i) based upon the Commercial Demand Forecast; ii) a multiple of the Minimum <strong>Batch Size</strong>; and iii) subject to adjustment upon mutual agreement of both Parties (\u201cMinimum Annual Commercial Commitment\u201d).", "After the Facility is established, Nordion agrees, in consultation with BLSI, to develop and implement a Master Validation Plan for the Facility that will allow the production of Altropane under cGMPs to those volumes required by BLSI, not to exceed the Maximum <strong>Batch Size</strong>.", "These are set forth below (or as mutually agreed in writing by the Parties): Product <strong>Batch Size</strong> - Expected Yield Products A and C 1 mg.", "Ops Title: President Date: 11-6-00 Date: 11-3-00 Standard <strong>Batch Size</strong> Large Freeze Dryer Small Freeze Dryer 5 dose [ *** ] units [ *** ]ds [ *** ] units [ *** ] ds 10 dose [ *** ] units [ *** ]ds [ *** ] units [ *** ] ds 50 dose [ *** ] units [ *** ]ds [ *** ] units [ *** ] ds NOTE: THESE PRICES ARE IN EFFECT FOR DELIVERIES MADE BETWEEN 1/1/2001 AND 12/31/2001 INCLUDING PURCHASE ORDERS PLACED AFTER 8/1/2000 Those products that are no longer carried are not included in this price restructure."], "related": [["batch", "Batch", "Batch"], ["process-weight", "Process weight", "Process weight"], ["drug-substance", "Drug Substance", "Drug Substance"], ["technical-specification", "technical specification", "technical specification"], ["batch-number", "Batch number", "Batch number"]], "related_snippets": [], "updated": "2025-09-27T06:38:08+00:00"}, "json": true, "cursor": ""}}